Journal of Microbiology and Biotechnology
The Korean Society for Microbiology and Biotechnology publishes the Journal of Microbiology and Biotechnology.

2019 ; Vol.29-3: 367~372

AuthorNguyen Lan Huong, Na Joon Lee, Hyun Ha Hwang, Hye Bin Son, Hye Ji Kim, Eun Gyo Seo, Nguyen Huu Hoang, Je Won Park
Place of dutyDepartment of Biotechnology Convergent Pharmaceutical Engineering, SunMoon University
TitleIn Vivo Characterization of Phosphotransferase-Encoding Genes istP and forP as Interchangeable Launchers of the C3’,4’-Dideoxygenation Biosynthetic Pathway of 1,4-Diaminocyclitol Antibiotics
PublicationInfo J. Microbiol. Biotechnol.2019 ; Vol.29-3
AbstractDeactivation of aminoglycosides by their modifying enzymes, including a number of aminoglycoside O-phosphotransferases, is the most ubiquitous resistance mechanism in aminoglycoside-resistant pathogens. Nonetheless, in a couple of biosynthetic pathways for gentamicins, fortimicins, and istamycins, phosphorylation of aminoglycosides seems to be a unique and initial step for the creation of a natural defensive structural feature such as a 3’,4’- dideoxy scaffold. Our aim was to elucidate the biochemical details on the beginning of these C3’,4’-dideoxygenation biosynthetic steps for aminoglycosides. The biosynthesis of istamycins must surely involve these 3’,4’-didehydroxylation steps, but much less has been reported in terms of characterization of istamycin biosynthetic genes, especially about the phosphotransferase-encoding gene. In the disruption and complementation experiments pointing to a putative gene, istP, in the genome of wild-type Streptomyces tenjimariensis, the function of the istP gene was proved here to be a phosphotransferase. Next, an in-frame deletion of a known phosphotransferase-encoding gene forP from the genome of wild-type Micromonospora olivasterospora resulted in the appearance of a hitherto unidentified fortimicin shunt product, namely 3-O-methyl-FOR-KK1, whereas complementation of forP restored the natural fortimicin metabolite profiles. The bilateral complementation of an istP gene (or forP) in the ΔforP mutant ( or ΔistP mutant strain) successfully restored the biosynthesis of 3’,4’- dideoxy fortimicins and istamycins , thus clearly indicating that they are interchangeable launchers of the biosynthesis of 3’,4’-dideoxy types of 1,4-diaminocyclitol antibiotics.
Supplemental Data
Key_wordAminoglycoside, istamycin, fortimicin, istP, 1-O-methyl-FOR-KK1
  1. Park SR, Park JW, Ban YH, Sohng JK, Yoon YJ. 2013. 2Deoxystreptamine-containing aminoglycoside antibiotics:recent advances in the characterization and manipulation of their biosynthetic pathways. Nat. Prod. Rep. 30: 11-20.
  2. Pokrovskaya V, Nudelman I, Kandasamy J, Baasov T. 2010. Aminoglycosides redesign strategies for improved antibiotics and compounds for treatment of human genetic diseases. Methods Enzymol. 478: 437-462.
  3. Park JW, Nam SJ, Yoon YJ. 2017. Enabling techniques in the search for new antibiotics: combinatorial biosynthesis of sugar-containing antibiotics. Biochem. Pharmacol. 134: 56-73.
  4. Yamamoto M, Okachi R, Kawamoto I, Nara T. 1977. Fortimicin A production by Micromonospora olivoasterospora in a chemically defined medium, J. Antibiot. (Tokyo) 30: 1064-1072.
  5. Ikeda D, Miyasaka T, Yoshida M, Horiuchi Y, Kondo S, Umezawa H. 1979. Synthesis of istamycin A. J. Antibiot. (Tokyo) 32: 1365-1366.
  6. Matsuhashi Y, Yoshida T, Hara T, Kazuno Y, Inouye S. 1985. In vitro and in vivo antibacterial activities of dactimicin, a novel pseudodisaccharide aminoglycoside, compared with those of other aminoglycoside antibiotics, Antimicrob. Agents Chemother. 27: 589-594.
  7. Ramirez MS, Tolmasky ME. 2010. Aminoglycoside modifying enzymes. Drug Resist. Updat. 13: 151-171.
  8. Park JW, Ban YH, Nam SJ, Cha SS, Yoon YJ. 2017. Biosynthetic pathways of aminoglycosides and their engineering. Curr. Opin. Biotechnol. 48: 33-41.
  9. Dairi T, Ohta T, Hashimoto E, Hasegawa M. 1992. Organization and nature of fortimicin A (astromicin) biosynthetic genes studied using a cosmid library of Micromonospora olivasterospora DNA. Mol. Gen. Genet. 236: 39-48.
  10. Shao L, Chen J, Wang C, Li JA, Tang Y, Chen D, Liu W. 2013. Characterization of a key aminoglycoside phosphotransferase in gentamicin biosynthesis. Bioorg. Med. Chem. Lett. 23: 1438-1441.
  11. Li S, Guo J, Reva A, Huang F, Xiong B, Liu Y, et al. 2018. Methyltransferases of gentamicin biosynthesis. Proc. Natl. Acad. Sci. USA 115: 1340-1345.
  12. MacNeil DJ, Gewain KM, Ruby CL, Dezeny G, Gibbons PH, MacNeil T. 1992. Analysis of Streptomyces avermitilis genes required for avermectin biosynthesis utilizing a novel integration vector. Gene 111: 61-68.
  13. Hoang NH, Huong NL, Kim B, Sohng JK, Yoon YJ, Park JW. 2016. Istamycin aminoglycosides profiling and their characterization in Streptomyces tenjimariensis ATCC 31603 culture using high-performance liquid chromatography with tandem mass spectrometry. J. Sep. Sci. 39: 4712-4722.
  14. Park JW, Park SR, Nepal KK, Han AR, Ban YH, Yoo YJ, et al. 2011. Discovery of parallel pathways of kanamycin biosynthesis allows antibiotic manipulation, Nat. Chem. Biol.7: 843-852.
  15. Huong NL, Hoang NH, Hong SY, Sohng JK, Yoon YJ, Park JW. 2016. Characterization of fortimicin aminoglycoside profiles produced from Micromonospora olivasterospora DSM 43868 by high-performance liquid chromatography-electrospray ionization-ion trap-mass spectrometry. Anal. Bioanal. Chem. 408: 1667-1678.

Copyright © 2009 by the Korean Society for Microbiology and Biotechnology.
All right reserved. Mail to
Online ISSN: 1738-8872    Print ISSN: 1017-7825    Powered by, Ltd